Evolus, Inc. SEC filings EOLS
Evolus, Inc. has 557 filings in SEC EDGAR's recent list, going back to Feb 27, 2013. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Jun 5, 2026 | — |
| S-8 | Employee stock plan registration | Mar 3, 2026 | — |
| S-8 | Employee stock plan registration | Mar 4, 2025 | — |
| S-8 | Employee stock plan registration | Nov 6, 2024 | — |
| 424B5 | Prospectus supplement | Mar 11, 2024 | — |
| S-8 | Employee stock plan registration | Mar 7, 2024 | — |
| S-8 | Employee stock plan registration | Oct 6, 2023 | — |
| 424B5 | Prospectus supplement | Jun 9, 2023 | — |
| S-3/A | Filing | Jun 7, 2023 | — |
| S-3/A | Filing | Apr 14, 2023 | — |
| S-3 | Shelf registration | Mar 8, 2023 | — |
| S-8 | Employee stock plan registration | Mar 8, 2023 | — |
| S-8 | Employee stock plan registration | Sep 9, 2022 | — |
| S-8 | Employee stock plan registration | Mar 4, 2022 | — |
| 424B5 | Prospectus supplement | Apr 22, 2021 | — |
| S-3MEF | Filing | Apr 21, 2021 | — |
| 424B5 | Prospectus supplement | Apr 21, 2021 | — |
| S-8 | Employee stock plan registration | Mar 26, 2021 | — |
| 424B5 | Prospectus supplement | Mar 26, 2021 | — |
| S-8 | Employee stock plan registration | Feb 25, 2020 | — |
| 424B5 | Prospectus supplement | Nov 7, 2019 | — |
| 424B5 | Prospectus supplement | Nov 6, 2019 | — |
| 424B4 | Prospectus | May 17, 2019 | — |
| 424B4 | Prospectus | May 15, 2019 | — |
| S-3/A | Filing | Apr 10, 2019 | — |
| S-3 | Shelf registration | Mar 22, 2019 | — |
| S-8 | Employee stock plan registration | Jan 10, 2019 | — |
| 424B4 | Prospectus | Jul 20, 2018 | — |
| FWP | Free writing prospectus | Jul 19, 2018 | — |
| S-1 | Registration statement | Jul 16, 2018 | — |
| S-8 | Employee stock plan registration | Feb 16, 2018 | — |
| 424B4 | Prospectus | Feb 9, 2018 | — |
| S-1/A | Amended registration statement | Feb 1, 2018 | — |
| S-1/A | Amended registration statement | Jan 29, 2018 | — |
| S-1/A | Amended registration statement | Jan 25, 2018 | — |
| S-1 | Registration statement | Jan 9, 2018 | — |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EOLS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Newport Beach, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1570562
- Former names
- Evolus, Inc. (until Nov 4, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.